LEE ANN L.
SEC insider (Form 3/4/5 filer). CIK 0001723629. Chief Technical Officer at Prime Medicine, Inc. (PRME). 8 reported Form 4/5 transactions since Sep 2024; latest on Feb 23, 2026. Located in CAMBRIDGE, MA.
Companies LEE ANN L. has filed insider reports for
- Prime Medicine, Inc. (PRME): Officer, Chief Technical Officer
LEE ANN L.
CIK: 0001723629
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Prime Medicine, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Feb 23, 2026PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
375K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
DispositionDirectStock Option (right to buy)
181K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
181K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
DispositionDirectStock Option (right to buy)
181K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
181K shares- - May 21, 2025PRME
Prime Medicine, Inc.
PurchaseDirect100K shares at avg. $1.13$113K - May 8, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
80.4K shares- - Feb 27, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
275K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 23, 2026 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 375,000 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Disposition Stock Option (right to buy) | 180,995 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 180,995 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Disposition Stock Option (right to buy) | 180,995 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 180,995 | - | - | Direct |
| May 21, 2025 | PRME Prime Medicine, Inc. | Purchase | 100,000 | $1.13 | $113,000 | Direct |
| May 8, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 80,416 | - | - | Direct |
| Feb 27, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 275,000 | - | - | Direct |
1-8 of 8 transactions